#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=Researchers identify protein responsible for malaria transmission
1-1	0-11	Researchers	person	new	coref	4-4
1-2	12-20	identify	_	_	_	_
1-3	21-28	protein	substance[2]	new[2]	coref	4-8[13_2]
1-4	29-40	responsible	substance[2]	new[2]	_	_
1-5	41-44	for	_	_	_	_
1-6	45-52	malaria	abstract|abstract[4]	new|new[4]	coref|coref	4-13|4-13[15_4]
1-7	53-65	transmission	abstract[4]	new[4]	_	_

#Text=Tuesday , February 25 , 2014
2-1	66-73	Tuesday	time	new	appos	2-3[6_0]
2-2	74-75	,	_	_	_	_
2-3	76-84	February	time[6]	giv[6]	_	_
2-4	85-87	25	time[6]	giv[6]	_	_
2-5	88-89	,	time[6]	giv[6]	_	_
2-6	90-94	2014	time[6]|time	giv[6]|new	_	_

#Text=Plasmodium falciparum gametocytes .
3-1	95-105	Plasmodium	substance|abstract[9]|animal[10]	new|new[9]|new[10]	coref|coref|coref	5-13[25_10]|7-5|10-3[0_9]
3-2	106-116	falciparum	abstract[9]|animal[10]	new[9]|new[10]	_	_
3-3	117-128	gametocytes	animal[10]	new[10]	_	_
3-4	129-130	.	_	_	_	_

#Text=Two groups of researchers have independently identified the the protein responsible for malaria transmission to mosquitoes in studies published in journal Nature on Sunday .
4-1	131-134	Two	person[11]	new[11]	coref	24-6[163_11]
4-2	135-141	groups	person[11]	new[11]	_	_
4-3	142-144	of	person[11]	new[11]	_	_
4-4	145-156	researchers	person[11]|person	new[11]|giv	coref	12-1[79_0]
4-5	157-161	have	_	_	_	_
4-6	162-175	independently	_	_	_	_
4-7	176-186	identified	_	_	_	_
4-8	187-190	the	substance[13]	giv[13]	coref	5-8[22_13]
4-9	191-194	the	substance[13]	giv[13]	_	_
4-10	195-202	protein	substance[13]	giv[13]	_	_
4-11	203-214	responsible	substance[13]	giv[13]	_	_
4-12	215-218	for	substance[13]	giv[13]	_	_
4-13	219-226	malaria	substance[13]|abstract|abstract[15]	giv[13]|giv|giv[15]	coref|coref	5-13|5-28[28_15]
4-14	227-239	transmission	substance[13]|abstract[15]	giv[13]|giv[15]	_	_
4-15	240-242	to	substance[13]|abstract[15]	giv[13]|giv[15]	_	_
4-16	243-253	mosquitoes	substance[13]|abstract[15]|animal	giv[13]|giv[15]|new	coref	6-6
4-17	254-256	in	_	_	_	_
4-18	257-264	studies	abstract[17]	new[17]	_	_
4-19	265-274	published	abstract[17]	new[17]	_	_
4-20	275-277	in	abstract[17]	new[17]	_	_
4-21	278-285	journal	abstract[17]|organization[18]	new[17]|new[18]	_	_
4-22	286-292	Nature	abstract[17]|organization[18]	new[17]|new[18]	_	_
4-23	293-295	on	abstract[17]	new[17]	_	_
4-24	296-302	Sunday	abstract[17]|time	new[17]|new	coref	20-29[129_0]
4-25	303-304	.	_	_	_	_

#Text=The scientists found a direct relationship between the protein AP2-G 's with malaria gametocytes ( male and female sexual forms ) production , which is necessary for the transmission .
5-1	305-308	The	person[20]	new[20]	_	_
5-2	309-319	scientists	person[20]	new[20]	_	_
5-3	320-325	found	_	_	_	_
5-4	326-327	a	abstract[21]	new[21]	_	_
5-5	328-334	direct	abstract[21]	new[21]	_	_
5-6	335-347	relationship	abstract[21]	new[21]	_	_
5-7	348-355	between	abstract[21]	new[21]	_	_
5-8	356-359	the	abstract[21]|substance[22]|substance[23]	new[21]|giv[22]|giv[23]	coref|coref	5-8[23_22]|10-26[0_23]
5-9	360-367	protein	abstract[21]|substance[22]|substance[23]	new[21]|giv[22]|giv[23]	_	_
5-10	368-373	AP2-G	abstract[21]|substance[22]|substance[23]	new[21]|giv[22]|giv[23]	_	_
5-11	374-376	's	abstract[21]|substance[22]|substance[23]	new[21]|giv[22]|giv[23]	_	_
5-12	377-381	with	abstract[21]	new[21]	_	_
5-13	382-389	malaria	abstract[21]|abstract|animal[25]|abstract[27]	new[21]|giv|giv[25]|new[27]	coref|coref	7-1|12-29[0_25]
5-14	390-401	gametocytes	abstract[21]|animal[25]|abstract[27]	new[21]|giv[25]|new[27]	_	_
5-15	402-403	(	abstract[21]|abstract[27]	new[21]|new[27]	_	_
5-16	404-408	male	abstract[21]|substance[26]|abstract[27]	new[21]|new[26]|new[27]	coref	6-1[29_26]
5-17	409-412	and	abstract[21]|substance[26]|abstract[27]	new[21]|new[26]|new[27]	_	_
5-18	413-419	female	abstract[21]|substance[26]|abstract[27]	new[21]|new[26]|new[27]	_	_
5-19	420-426	sexual	abstract[21]|substance[26]|abstract[27]	new[21]|new[26]|new[27]	_	_
5-20	427-432	forms	abstract[21]|substance[26]|abstract[27]	new[21]|new[26]|new[27]	_	_
5-21	433-434	)	abstract[21]|abstract[27]	new[21]|new[27]	_	_
5-22	435-445	production	abstract[21]|abstract[27]	new[21]|new[27]	_	_
5-23	446-447	,	abstract[21]|abstract[27]	new[21]|new[27]	_	_
5-24	448-453	which	abstract[21]|abstract[27]	new[21]|new[27]	_	_
5-25	454-456	is	abstract[21]|abstract[27]	new[21]|new[27]	_	_
5-26	457-466	necessary	abstract[21]|abstract[27]	new[21]|new[27]	_	_
5-27	467-470	for	abstract[21]|abstract[27]	new[21]|new[27]	_	_
5-28	471-474	the	abstract[21]|abstract[27]|abstract[28]	new[21]|new[27]|giv[28]	coref	14-10[95_28]
5-29	475-487	transmission	abstract[21]|abstract[27]|abstract[28]	new[21]|new[27]|giv[28]	_	_
5-30	488-489	.	_	_	_	_

#Text=Only the sexual forms infect mosquitoes and sexual reproduction occurs within the mosquito digestive tract .
6-1	490-494	Only	substance[29]	giv[29]	coref	22-24[155_29]
6-2	495-498	the	substance[29]	giv[29]	_	_
6-3	499-505	sexual	substance[29]	giv[29]	_	_
6-4	506-511	forms	substance[29]	giv[29]	_	_
6-5	512-518	infect	_	_	_	_
6-6	519-529	mosquitoes	animal	giv	coref	20-35[131_0]
6-7	530-533	and	_	_	_	_
6-8	534-540	sexual	event[31]	new[31]	_	_
6-9	541-553	reproduction	event[31]	new[31]	_	_
6-10	554-560	occurs	_	_	_	_
6-11	561-567	within	_	_	_	_
6-12	568-571	the	object[33]	new[33]	_	_
6-13	572-580	mosquito	animal|object[33]	new|new[33]	coref	18-5[115_0]
6-14	581-590	digestive	object[33]	new[33]	_	_
6-15	591-596	tract	object[33]	new[33]	_	_
6-16	597-598	.	_	_	_	_

#Text=Malaria is caused by Plasmodium parasites .
7-1	599-606	Malaria	abstract	giv	coref	21-13
7-2	607-609	is	_	_	_	_
7-3	610-616	caused	_	_	_	_
7-4	617-619	by	_	_	_	_
7-5	620-630	Plasmodium	substance|animal[36]	giv|new[36]	coref|coref	8-8|18-1[114_36]
7-6	631-640	parasites	animal[36]	new[36]	_	_
7-7	641-642	.	_	_	_	_

#Text=The initially separate teams looked at different plasmodium species .
8-1	643-646	The	organization[37]	new[37]	coref	17-1[105_37]
8-2	647-656	initially	organization[37]	new[37]	_	_
8-3	657-665	separate	organization[37]	new[37]	_	_
8-4	666-671	teams	organization[37]	new[37]	_	_
8-5	672-678	looked	_	_	_	_
8-6	679-681	at	_	_	_	_
8-7	682-691	different	animal[39]	new[39]	_	_
8-8	692-702	plasmodium	substance|animal[39]	giv|new[39]	coref	9-19[47_0]
8-9	703-710	species	animal[39]	new[39]	_	_
8-10	711-712	.	_	_	_	_

#Text=One , an international group led by Manuel Llinás of Penn State University in the US , examined Plasmodium falciparum , which is responsible for the worst form of human malarial infections ; the other , led by UK scientists Oliver Billker from the Wellcome Trust Sanger Institute in England and Andy Waters from University of Glasgow in Scotland , looked at Plasmodium berghei , which infects rodents .
9-1	713-716	One	person	new	_	_
9-2	717-718	,	_	_	_	_
9-3	719-721	an	organization[41]	new[41]	coref	10-1[63_41]
9-4	722-735	international	organization[41]	new[41]	_	_
9-5	736-741	group	organization[41]	new[41]	_	_
9-6	742-745	led	organization[41]	new[41]	_	_
9-7	746-748	by	organization[41]	new[41]	_	_
9-8	749-755	Manuel	organization[41]|person[42]	new[41]|new[42]	_	_
9-9	756-762	Llinás	organization[41]|person[42]	new[41]|new[42]	_	_
9-10	763-765	of	organization[41]|person[42]	new[41]|new[42]	_	_
9-11	766-770	Penn	organization[41]|person[42]|place|organization[45]	new[41]|new[42]|new|new[45]	_	_
9-12	771-776	State	organization[41]|person[42]|place|organization[45]	new[41]|new[42]|new|new[45]	_	_
9-13	777-787	University	organization[41]|person[42]|organization[45]	new[41]|new[42]|new[45]	_	_
9-14	788-790	in	organization[41]|person[42]|organization[45]	new[41]|new[42]|new[45]	_	_
9-15	791-794	the	organization[41]|person[42]|organization[45]|place[46]	new[41]|new[42]|new[45]|new[46]	_	_
9-16	795-797	US	organization[41]|person[42]|organization[45]|place[46]	new[41]|new[42]|new[45]|new[46]	_	_
9-17	798-799	,	_	_	_	_
9-18	800-808	examined	_	_	_	_
9-19	809-819	Plasmodium	substance[47]	giv[47]	coref	9-63[59_47]
9-20	820-830	falciparum	substance[47]	giv[47]	_	_
9-21	831-832	,	substance[47]	giv[47]	_	_
9-22	833-838	which	substance[47]	giv[47]	_	_
9-23	839-841	is	substance[47]	giv[47]	_	_
9-24	842-853	responsible	substance[47]	giv[47]	_	_
9-25	854-857	for	substance[47]	giv[47]	_	_
9-26	858-861	the	substance[47]|abstract[48]	giv[47]|new[48]	_	_
9-27	862-867	worst	substance[47]|abstract[48]	giv[47]|new[48]	_	_
9-28	868-872	form	substance[47]|abstract[48]	giv[47]|new[48]	_	_
9-29	873-875	of	substance[47]|abstract[48]	giv[47]|new[48]	_	_
9-30	876-881	human	substance[47]|abstract[48]|abstract[49]	giv[47]|new[48]|new[49]	_	_
9-31	882-890	malarial	substance[47]|abstract[48]|abstract[49]	giv[47]|new[48]|new[49]	_	_
9-32	891-901	infections	substance[47]|abstract[48]|abstract[49]	giv[47]|new[48]|new[49]	_	_
9-33	902-903	;	_	_	_	_
9-34	904-907	the	_	_	_	_
9-35	908-913	other	_	_	_	_
9-36	914-915	,	_	_	_	_
9-37	916-919	led	_	_	_	_
9-38	920-922	by	_	_	_	_
9-39	923-925	UK	person[50]	new[50]	coref	21-1[133_50]
9-40	926-936	scientists	person[50]	new[50]	_	_
9-41	937-943	Oliver	person[50]	new[50]	_	_
9-42	944-951	Billker	_	_	_	_
9-43	952-956	from	_	_	_	_
9-44	957-960	the	organization[54]	new[54]	_	_
9-45	961-969	Wellcome	organization|abstract[52]|organization[54]	new|new[52]|new[54]	_	_
9-46	970-975	Trust	abstract[52]|organization[54]	new[52]|new[54]	_	_
9-47	976-982	Sanger	place|organization[54]	new|new[54]	_	_
9-48	983-992	Institute	organization[54]	new[54]	_	_
9-49	993-995	in	organization[54]	new[54]	_	_
9-50	996-1003	England	organization[54]|place	new[54]|new	coref	12-3
9-51	1004-1007	and	_	_	_	_
9-52	1008-1012	Andy	_	_	_	_
9-53	1013-1019	Waters	_	_	_	_
9-54	1020-1024	from	_	_	_	_
9-55	1025-1035	University	organization[56]	new[56]	_	_
9-56	1036-1038	of	organization[56]	new[56]	_	_
9-57	1039-1046	Glasgow	organization[56]|place	new[56]|new	_	_
9-58	1047-1049	in	organization[56]	new[56]	_	_
9-59	1050-1058	Scotland	organization[56]|place	new[56]|new	_	_
9-60	1059-1060	,	_	_	_	_
9-61	1061-1067	looked	_	_	_	_
9-62	1068-1070	at	_	_	_	_
9-63	1071-1081	Plasmodium	substance[59]	giv[59]	_	_
9-64	1082-1089	berghei	substance[59]	giv[59]	_	_
9-65	1090-1091	,	substance[59]	giv[59]	_	_
9-66	1092-1097	which	substance[59]	giv[59]	_	_
9-67	1098-1105	infects	substance[59]	giv[59]	_	_
9-68	1106-1113	rodents	substance[59]|animal	giv[59]|new	_	_
9-69	1114-1115	.	_	_	_	_

#Text=The P. falciparum group was kickstarted by research in Spain which found different organisms from the same strain with identical DNA had varying levels of AP2-G , with a strong correlation to their levels of sexual activity .
10-1	1116-1119	The	organization[63]	giv[63]	_	_
10-2	1120-1122	P.	person|organization[63]	new|giv[63]	coref	12-21
10-3	1123-1133	falciparum	abstract|organization[63]	giv|giv[63]	coref	12-21[85_0]
10-4	1134-1139	group	organization[63]	giv[63]	_	_
10-5	1140-1143	was	_	_	_	_
10-6	1144-1155	kickstarted	_	_	_	_
10-7	1156-1158	by	_	_	_	_
10-8	1159-1167	research	abstract[64]	new[64]	coref	23-6[158_64]
10-9	1168-1170	in	abstract[64]	new[64]	_	_
10-10	1171-1176	Spain	abstract[64]|place	new[64]|new	_	_
10-11	1177-1182	which	abstract[64]	new[64]	_	_
10-12	1183-1188	found	abstract[64]	new[64]	_	_
10-13	1189-1198	different	abstract[64]|animal[66]	new[64]|new[66]	ana	10-33[0_66]
10-14	1199-1208	organisms	abstract[64]|animal[66]	new[64]|new[66]	_	_
10-15	1209-1213	from	abstract[64]|animal[66]	new[64]|new[66]	_	_
10-16	1214-1217	the	abstract[64]|animal[66]|animal[67]	new[64]|new[66]|new[67]	coref	17-16[109_67]
10-17	1218-1222	same	abstract[64]|animal[66]|animal[67]	new[64]|new[66]|new[67]	_	_
10-18	1223-1229	strain	abstract[64]|animal[66]|animal[67]	new[64]|new[66]|new[67]	_	_
10-19	1230-1234	with	abstract[64]|animal[66]|animal[67]	new[64]|new[66]|new[67]	_	_
10-20	1235-1244	identical	abstract[64]|animal[66]|animal[67]|abstract[68]	new[64]|new[66]|new[67]|new[68]	_	_
10-21	1245-1248	DNA	abstract[64]|animal[66]|animal[67]|abstract[68]	new[64]|new[66]|new[67]|new[68]	_	_
10-22	1249-1252	had	abstract[64]	new[64]	_	_
10-23	1253-1260	varying	abstract[64]|abstract[69]	new[64]|new[69]	_	_
10-24	1261-1267	levels	abstract[64]|abstract[69]	new[64]|new[69]	_	_
10-25	1268-1270	of	abstract[64]|abstract[69]	new[64]|new[69]	_	_
10-26	1271-1276	AP2-G	abstract[64]|abstract[69]|substance	new[64]|new[69]|giv	coref	11-1[75_0]
10-27	1277-1278	,	_	_	_	_
10-28	1279-1283	with	_	_	_	_
10-29	1284-1285	a	abstract[71]	new[71]	_	_
10-30	1286-1292	strong	abstract[71]	new[71]	_	_
10-31	1293-1304	correlation	abstract[71]	new[71]	_	_
10-32	1305-1307	to	abstract[71]	new[71]	_	_
10-33	1308-1313	their	abstract[71]|animal|abstract[73]	new[71]|giv|new[73]	_	_
10-34	1314-1320	levels	abstract[71]|abstract[73]	new[71]|new[73]	_	_
10-35	1321-1323	of	abstract[71]|abstract[73]	new[71]|new[73]	_	_
10-36	1324-1330	sexual	abstract[71]|abstract[73]|event[74]	new[71]|new[73]|new[74]	_	_
10-37	1331-1339	activity	abstract[71]|abstract[73]|event[74]	new[71]|new[73]|new[74]	_	_
10-38	1340-1341	.	_	_	_	_

#Text=The more AP2-G , the higher the rate of gametocyte formation .
11-1	1342-1345	The	substance[75]	giv[75]	coref	13-10[0_75]
11-2	1346-1350	more	substance[75]	giv[75]	_	_
11-3	1351-1356	AP2-G	substance[75]	giv[75]	_	_
11-4	1357-1358	,	_	_	_	_
11-5	1359-1362	the	_	_	_	_
11-6	1363-1369	higher	_	_	_	_
11-7	1370-1373	the	abstract[76]	new[76]	_	_
11-8	1374-1378	rate	abstract[76]	new[76]	_	_
11-9	1379-1381	of	abstract[76]	new[76]	_	_
11-10	1382-1392	gametocyte	abstract[76]|abstract|event[78]	new[76]|new|new[78]	coref	20-4[121_78]
11-11	1393-1402	formation	abstract[76]|event[78]	new[76]|new[78]	_	_
11-12	1403-1404	.	_	_	_	_

#Text=Researchers in England , later also drawn into the international team , analyzed the genomes of two mutated strains of P. falciparum which were both unable to form gametocytes .
12-1	1405-1416	Researchers	person[79]	giv[79]	ana	13-1[0_79]
12-2	1417-1419	in	person[79]	giv[79]	_	_
12-3	1420-1427	England	person[79]|place	giv[79]|giv	_	_
12-4	1428-1429	,	person[79]	giv[79]	_	_
12-5	1430-1435	later	person[79]	giv[79]	_	_
12-6	1436-1440	also	person[79]	giv[79]	_	_
12-7	1441-1446	drawn	person[79]	giv[79]	_	_
12-8	1447-1451	into	person[79]	giv[79]	_	_
12-9	1452-1455	the	person[79]|person[81]	giv[79]|new[81]	coref	14-1[92_81]
12-10	1456-1469	international	person[79]|person[81]	giv[79]|new[81]	_	_
12-11	1470-1474	team	person[79]|person[81]	giv[79]|new[81]	_	_
12-12	1475-1476	,	_	_	_	_
12-13	1477-1485	analyzed	_	_	_	_
12-14	1486-1489	the	object[82]	new[82]	_	_
12-15	1490-1497	genomes	object[82]	new[82]	_	_
12-16	1498-1500	of	object[82]	new[82]	_	_
12-17	1501-1504	two	object[82]|animal[83]	new[82]|new[83]	_	_
12-18	1505-1512	mutated	object[82]|animal[83]	new[82]|new[83]	_	_
12-19	1513-1520	strains	object[82]|animal[83]	new[82]|new[83]	_	_
12-20	1521-1523	of	object[82]|animal[83]	new[82]|new[83]	_	_
12-21	1524-1526	P.	object[82]|animal[83]|person|abstract[85]	new[82]|new[83]|giv|giv[85]	_	_
12-22	1527-1537	falciparum	object[82]|animal[83]|abstract[85]	new[82]|new[83]|giv[85]	_	_
12-23	1538-1543	which	object[82]|animal[83]	new[82]|new[83]	_	_
12-24	1544-1548	were	object[82]|animal[83]	new[82]|new[83]	_	_
12-25	1549-1553	both	object[82]|animal[83]	new[82]|new[83]	_	_
12-26	1554-1560	unable	object[82]|animal[83]	new[82]|new[83]	_	_
12-27	1561-1563	to	object[82]|animal[83]	new[82]|new[83]	_	_
12-28	1564-1568	form	object[82]|animal[83]|abstract	new[82]|new[83]|new	none|none	12-28[0_147]|17-24
12-29	1569-1580	gametocytes	object[82]|animal[83]|animal	new[82]|new[83]|giv	coref	17-25
12-30	1581-1582	.	_	_	_	_

#Text=They found that the gene responsible for producing the AP2-G protein was the only common non-functioning gene .
13-1	1583-1587	They	person	giv	coref	23-1[157_0]
13-2	1588-1593	found	_	_	_	_
13-3	1594-1598	that	_	_	_	_
13-4	1599-1602	the	abstract[88]	new[88]	coref	13-13[91_88]
13-5	1603-1607	gene	abstract[88]	new[88]	_	_
13-6	1608-1619	responsible	abstract[88]	new[88]	_	_
13-7	1620-1623	for	_	_	_	_
13-8	1624-1633	producing	_	_	_	_
13-9	1634-1637	the	substance[90]	giv[90]	coref|coref	13-9[90_0]|14-7[0_90]
13-10	1638-1643	AP2-G	substance|substance[90]	giv|giv[90]	_	_
13-11	1644-1651	protein	substance[90]	giv[90]	_	_
13-12	1652-1655	was	_	_	_	_
13-13	1656-1659	the	abstract[91]	giv[91]	coref	14-16[0_91]
13-14	1660-1664	only	abstract[91]	giv[91]	_	_
13-15	1665-1671	common	abstract[91]	giv[91]	_	_
13-16	1672-1687	non-functioning	abstract[91]	giv[91]	_	_
13-17	1688-1692	gene	abstract[91]	giv[91]	_	_
13-18	1693-1694	.	_	_	_	_

#Text=The international team found found the AP2-G protein catalyzes the transmission by activating a relevant gene set in the parasite .
14-1	1695-1698	The	person[92]	giv[92]	coref	20-11[123_92]
14-2	1699-1712	international	person[92]	giv[92]	_	_
14-3	1713-1717	team	person[92]	giv[92]	_	_
14-4	1718-1723	found	_	_	_	_
14-5	1724-1729	found	_	_	_	_
14-6	1730-1733	the	substance[94]	giv[94]	coref	14-6[94_0]
14-7	1734-1739	AP2-G	substance|substance[94]	giv|giv[94]	_	_
14-8	1740-1747	protein	substance[94]	giv[94]	_	_
14-9	1748-1757	catalyzes	_	_	_	_
14-10	1758-1761	the	abstract[95]	giv[95]	coref	18-15[116_95]
14-11	1762-1774	transmission	abstract[95]	giv[95]	_	_
14-12	1775-1777	by	_	_	_	_
14-13	1778-1788	activating	_	_	_	_
14-14	1789-1790	a	abstract[97]	new[97]	_	_
14-15	1791-1799	relevant	abstract[97]	new[97]	_	_
14-16	1800-1804	gene	abstract|abstract[97]	giv|new[97]	coref	17-13[108_0]
14-17	1805-1808	set	abstract[97]	new[97]	_	_
14-18	1809-1811	in	abstract[97]	new[97]	_	_
14-19	1812-1815	the	abstract[97]|animal[98]	new[97]|new[98]	coref	18-18[117_98]
14-20	1816-1824	parasite	abstract[97]|animal[98]	new[97]|new[98]	_	_
14-21	1825-1826	.	_	_	_	_

#Text=Women tend to their malaria-infected babies in Angola .
15-1	1827-1832	Women	person	new	ana	15-4
15-2	1833-1837	tend	_	_	_	_
15-3	1838-1840	to	_	_	_	_
15-4	1841-1846	their	person|animal[101]	giv|new[101]	_	_
15-5	1847-1863	malaria-infected	animal[101]	new[101]	_	_
15-6	1864-1870	babies	animal[101]	new[101]	_	_
15-7	1871-1873	in	_	_	_	_
15-8	1874-1880	Angola	place	new	_	_
15-9	1881-1882	.	_	_	_	_

#Text=Image : USAID Africa .
16-1	1883-1888	Image	abstract	new	_	_
16-2	1889-1890	:	_	_	_	_
16-3	1891-1896	USAID	organization[104]	new[104]	_	_
16-4	1897-1903	Africa	organization[104]	new[104]	_	_
16-5	1904-1905	.	_	_	_	_

#Text=Both teams confirmed the finding by gene therapy — both by adding the gene into a mutated strain and observing its ability to form gametocytes , and the other way round .
17-1	1906-1910	Both	organization[105]	giv[105]	_	_
17-2	1911-1916	teams	organization[105]	giv[105]	_	_
17-3	1917-1926	confirmed	_	_	_	_
17-4	1927-1930	the	abstract[106]	new[106]	_	_
17-5	1931-1938	finding	abstract[106]	new[106]	_	_
17-6	1939-1941	by	_	_	_	_
17-7	1942-1946	gene	event[107]	new[107]	_	_
17-8	1947-1954	therapy	event[107]	new[107]	_	_
17-9	1955-1956	—	_	_	_	_
17-10	1957-1961	both	_	_	_	_
17-11	1962-1964	by	_	_	_	_
17-12	1965-1971	adding	_	_	_	_
17-13	1972-1975	the	abstract[108]	giv[108]	_	_
17-14	1976-1980	gene	abstract[108]	giv[108]	_	_
17-15	1981-1985	into	_	_	_	_
17-16	1986-1987	a	animal[109]	giv[109]	ana	17-21[0_109]
17-17	1988-1995	mutated	animal[109]	giv[109]	_	_
17-18	1996-2002	strain	animal[109]	giv[109]	_	_
17-19	2003-2006	and	_	_	_	_
17-20	2007-2016	observing	_	_	_	_
17-21	2017-2020	its	animal|abstract[111]	giv|new[111]	_	_
17-22	2021-2028	ability	abstract[111]	new[111]	_	_
17-23	2029-2031	to	abstract[111]	new[111]	_	_
17-24	2032-2036	form	abstract[111]|abstract	new[111]|new	coref	21-37[142_0]
17-25	2037-2048	gametocytes	abstract[111]|animal	new[111]|giv	coref	19-7
17-26	2049-2050	,	_	_	_	_
17-27	2051-2054	and	_	_	_	_
17-28	2055-2058	the	abstract[113]	new[113]	_	_
17-29	2059-2064	other	abstract[113]	new[113]	_	_
17-30	2065-2068	way	abstract[113]	new[113]	_	_
17-31	2069-2074	round	abstract[113]	new[113]	_	_
17-32	2075-2076	.	_	_	_	_

#Text=The parasites exist in a mosquito , then in a human , and require subsequent transmission for the parasite to spread .
18-1	2077-2080	The	animal[114]	giv[114]	_	_
18-2	2081-2090	parasites	animal[114]	giv[114]	_	_
18-3	2091-2096	exist	_	_	_	_
18-4	2097-2099	in	_	_	_	_
18-5	2100-2101	a	animal[115]	giv[115]	_	_
18-6	2102-2110	mosquito	animal[115]	giv[115]	_	_
18-7	2111-2112	,	_	_	_	_
18-8	2113-2117	then	_	_	_	_
18-9	2118-2120	in	_	_	_	_
18-10	2121-2122	a	_	_	_	_
18-11	2123-2128	human	_	_	_	_
18-12	2129-2130	,	_	_	_	_
18-13	2131-2134	and	_	_	_	_
18-14	2135-2142	require	_	_	_	_
18-15	2143-2153	subsequent	abstract[116]	giv[116]	coref	19-1[118_116]
18-16	2154-2166	transmission	abstract[116]	giv[116]	_	_
18-17	2167-2170	for	abstract[116]	giv[116]	_	_
18-18	2171-2174	the	abstract[116]|animal[117]	giv[116]|giv[117]	coref	20-1[120_117]
18-19	2175-2183	parasite	abstract[116]|animal[117]	giv[116]|giv[117]	_	_
18-20	2184-2186	to	_	_	_	_
18-21	2187-2193	spread	_	_	_	_
18-22	2194-2195	.	_	_	_	_

#Text=The transmission can only happen through gametocytes .
19-1	2196-2199	The	abstract[118]	giv[118]	coref	21-10[135_118]
19-2	2200-2212	transmission	abstract[118]	giv[118]	_	_
19-3	2213-2216	can	_	_	_	_
19-4	2217-2221	only	_	_	_	_
19-5	2222-2228	happen	_	_	_	_
19-6	2229-2236	through	_	_	_	_
19-7	2237-2248	gametocytes	animal	giv	coref	20-6[122_0]
19-8	2249-2250	.	_	_	_	_

#Text=The parasite triggers formation of the sexual gametocytes into the human 's circulatory system every two days in small quantities — not wasting energy on the process at the dry time of year when few mosquitoes are available — but little was known about the mechanism .
20-1	2251-2254	The	animal[120]	giv[120]	coref	21-41[143_120]
20-2	2255-2263	parasite	animal[120]	giv[120]	_	_
20-3	2264-2272	triggers	_	_	_	_
20-4	2273-2282	formation	event[121]	giv[121]	_	_
20-5	2283-2285	of	event[121]	giv[121]	_	_
20-6	2286-2289	the	event[121]|animal[122]	giv[121]|giv[122]	_	_
20-7	2290-2296	sexual	event[121]|animal[122]	giv[121]|giv[122]	_	_
20-8	2297-2308	gametocytes	event[121]|animal[122]	giv[121]|giv[122]	_	_
20-9	2309-2313	into	event[121]|animal[122]	giv[121]|giv[122]	_	_
20-10	2314-2317	the	event[121]|animal[122]|place[124]	giv[121]|giv[122]|new[124]	_	_
20-11	2318-2323	human	event[121]|animal[122]|person[123]|place[124]	giv[121]|giv[122]|giv[123]|new[124]	_	_
20-12	2324-2326	's	event[121]|animal[122]|person[123]|place[124]	giv[121]|giv[122]|giv[123]|new[124]	_	_
20-13	2327-2338	circulatory	event[121]|animal[122]|place[124]	giv[121]|giv[122]|new[124]	_	_
20-14	2339-2345	system	event[121]|animal[122]|place[124]	giv[121]|giv[122]|new[124]	_	_
20-15	2346-2351	every	time[125]	new[125]	_	_
20-16	2352-2355	two	time[125]	new[125]	_	_
20-17	2356-2360	days	time[125]	new[125]	_	_
20-18	2361-2363	in	_	_	_	_
20-19	2364-2369	small	substance[126]	new[126]	_	_
20-20	2370-2380	quantities	substance[126]	new[126]	_	_
20-21	2381-2382	—	_	_	_	_
20-22	2383-2386	not	_	_	_	_
20-23	2387-2394	wasting	_	_	_	_
20-24	2395-2401	energy	abstract	new	_	_
20-25	2402-2404	on	_	_	_	_
20-26	2405-2408	the	event[128]	new[128]	_	_
20-27	2409-2416	process	event[128]	new[128]	_	_
20-28	2417-2419	at	_	_	_	_
20-29	2420-2423	the	time[129]	giv[129]	_	_
20-30	2424-2427	dry	time[129]	giv[129]	_	_
20-31	2428-2432	time	time[129]	giv[129]	_	_
20-32	2433-2435	of	time[129]	giv[129]	_	_
20-33	2436-2440	year	time[129]|time	giv[129]|new	_	_
20-34	2441-2445	when	_	_	_	_
20-35	2446-2449	few	animal[131]	giv[131]	_	_
20-36	2450-2460	mosquitoes	animal[131]	giv[131]	_	_
20-37	2461-2464	are	_	_	_	_
20-38	2465-2474	available	_	_	_	_
20-39	2475-2476	—	_	_	_	_
20-40	2477-2480	but	_	_	_	_
20-41	2481-2487	little	_	_	_	_
20-42	2488-2491	was	_	_	_	_
20-43	2492-2497	known	_	_	_	_
20-44	2498-2503	about	_	_	_	_
20-45	2504-2507	the	abstract[132]	new[132]	_	_
20-46	2508-2517	mechanism	abstract[132]	new[132]	_	_
20-47	2518-2519	.	_	_	_	_

#Text=Dr. Oliver Billker commented on the potential of getting the transmission of malaria under control , unlike the existing focus on addressing the phrase causing the clinical symptoms , " Current drugs treat patients by killing the sexless form of the parasite in their blood — this is the detrimental stage of the malaria lifecycle that causes illness .
21-1	2520-2523	Dr.	person[133]	giv[133]	_	_
21-2	2524-2530	Oliver	person[133]	giv[133]	_	_
21-3	2531-2538	Billker	person[133]	giv[133]	_	_
21-4	2539-2548	commented	_	_	_	_
21-5	2549-2551	on	_	_	_	_
21-6	2552-2555	the	abstract[134]	new[134]	_	_
21-7	2556-2565	potential	abstract[134]	new[134]	_	_
21-8	2566-2568	of	abstract[134]	new[134]	_	_
21-9	2569-2576	getting	abstract[134]	new[134]	_	_
21-10	2577-2580	the	abstract[134]|abstract[135]	new[134]|giv[135]	_	_
21-11	2581-2593	transmission	abstract[134]|abstract[135]	new[134]|giv[135]	_	_
21-12	2594-2596	of	abstract[134]|abstract[135]	new[134]|giv[135]	_	_
21-13	2597-2604	malaria	abstract[134]|abstract[135]|abstract	new[134]|giv[135]|giv	coref	21-54
21-14	2605-2610	under	abstract[134]	new[134]	_	_
21-15	2611-2618	control	abstract[134]	new[134]	_	_
21-16	2619-2620	,	_	_	_	_
21-17	2621-2627	unlike	_	_	_	_
21-18	2628-2631	the	abstract[137]	new[137]	_	_
21-19	2632-2640	existing	abstract[137]	new[137]	_	_
21-20	2641-2646	focus	abstract[137]	new[137]	_	_
21-21	2647-2649	on	abstract[137]	new[137]	_	_
21-22	2650-2660	addressing	abstract[137]	new[137]	_	_
21-23	2661-2664	the	abstract[137]|abstract[138]	new[137]|new[138]	_	_
21-24	2665-2671	phrase	abstract[137]|abstract[138]	new[137]|new[138]	_	_
21-25	2672-2679	causing	abstract[137]|abstract[138]	new[137]|new[138]	_	_
21-26	2680-2683	the	abstract[137]|abstract[138]|abstract[139]	new[137]|new[138]|new[139]	_	_
21-27	2684-2692	clinical	abstract[137]|abstract[138]|abstract[139]	new[137]|new[138]|new[139]	_	_
21-28	2693-2701	symptoms	abstract[137]|abstract[138]|abstract[139]	new[137]|new[138]|new[139]	_	_
21-29	2702-2703	,	_	_	_	_
21-30	2704-2705	"	_	_	_	_
21-31	2706-2713	Current	substance[140]	new[140]	coref	23-8[159_140]
21-32	2714-2719	drugs	substance[140]	new[140]	_	_
21-33	2720-2725	treat	_	_	_	_
21-34	2726-2734	patients	person	new	ana	21-44
21-35	2735-2737	by	_	_	_	_
21-36	2738-2745	killing	_	_	_	_
21-37	2746-2749	the	abstract[142]	new[142]	ana	21-47[0_142]
21-38	2750-2757	sexless	abstract[142]	new[142]	_	_
21-39	2758-2762	form	abstract[142]	new[142]	_	_
21-40	2763-2765	of	abstract[142]	new[142]	_	_
21-41	2766-2769	the	abstract[142]|animal[143]	new[142]|giv[143]	_	_
21-42	2770-2778	parasite	abstract[142]|animal[143]	new[142]|giv[143]	_	_
21-43	2779-2781	in	abstract[142]|animal[143]	new[142]|giv[143]	_	_
21-44	2782-2787	their	abstract[142]|animal[143]|person|substance[145]	new[142]|giv[143]|giv|new[145]	_	_
21-45	2788-2793	blood	abstract[142]|animal[143]|substance[145]	new[142]|giv[143]|new[145]	_	_
21-46	2794-2795	—	_	_	_	_
21-47	2796-2800	this	abstract	giv	coref	21-49[147_0]
21-48	2801-2803	is	_	_	_	_
21-49	2804-2807	the	abstract[147]	giv[147]	_	_
21-50	2808-2819	detrimental	abstract[147]	giv[147]	_	_
21-51	2820-2825	stage	abstract[147]	giv[147]	_	_
21-52	2826-2828	of	abstract[147]	giv[147]	_	_
21-53	2829-2832	the	abstract[147]|abstract[149]	giv[147]|new[149]	_	_
21-54	2833-2840	malaria	abstract[147]|abstract|abstract[149]	giv[147]|giv|new[149]	coref	22-11
21-55	2841-2850	lifecycle	abstract[147]|abstract[149]	giv[147]|new[149]	_	_
21-56	2851-2855	that	abstract[147]|abstract[149]	giv[147]|new[149]	_	_
21-57	2856-2862	causes	abstract[147]|abstract[149]	giv[147]|new[149]	_	_
21-58	2863-2870	illness	abstract[147]|abstract[149]|event	giv[147]|new[149]|new	ana	22-3
21-59	2871-2872	.	_	_	_	_

#Text=However , it is now widely accepted that to eliminate malaria from an entire region , it will be equally important to kill the sexual forms that transmit the disease . "
22-1	2873-2880	However	_	_	_	_
22-2	2881-2882	,	_	_	_	_
22-3	2883-2885	it	event	giv	ana	22-17
22-4	2886-2888	is	_	_	_	_
22-5	2889-2892	now	_	_	_	_
22-6	2893-2899	widely	_	_	_	_
22-7	2900-2908	accepted	_	_	_	_
22-8	2909-2913	that	_	_	_	_
22-9	2914-2916	to	_	_	_	_
22-10	2917-2926	eliminate	_	_	_	_
22-11	2927-2934	malaria	abstract	giv	coref	22-29[156_0]
22-12	2935-2939	from	_	_	_	_
22-13	2940-2942	an	place[153]	new[153]	_	_
22-14	2943-2949	entire	place[153]	new[153]	_	_
22-15	2950-2956	region	place[153]	new[153]	_	_
22-16	2957-2958	,	_	_	_	_
22-17	2959-2961	it	event	giv	_	_
22-18	2962-2966	will	_	_	_	_
22-19	2967-2969	be	_	_	_	_
22-20	2970-2977	equally	_	_	_	_
22-21	2978-2987	important	_	_	_	_
22-22	2988-2990	to	_	_	_	_
22-23	2991-2995	kill	_	_	_	_
22-24	2996-2999	the	substance[155]	giv[155]	_	_
22-25	3000-3006	sexual	substance[155]	giv[155]	_	_
22-26	3007-3012	forms	substance[155]	giv[155]	_	_
22-27	3013-3017	that	substance[155]	giv[155]	_	_
22-28	3018-3026	transmit	substance[155]	giv[155]	_	_
22-29	3027-3030	the	substance[155]|abstract[156]	giv[155]|giv[156]	coref	23-14[161_156]
22-30	3031-3038	disease	substance[155]|abstract[156]	giv[155]|giv[156]	_	_
22-31	3039-3040	.	_	_	_	_
22-32	3041-3042	"	_	_	_	_

#Text=The researchers hope to continue research toward drugs to prevent the transmission of the disease .
23-1	3043-3046	The	person[157]	giv[157]	_	_
23-2	3047-3058	researchers	person[157]	giv[157]	_	_
23-3	3059-3063	hope	_	_	_	_
23-4	3064-3066	to	_	_	_	_
23-5	3067-3075	continue	_	_	_	_
23-6	3076-3084	research	abstract[158]	giv[158]	coref	24-9[0_158]
23-7	3085-3091	toward	abstract[158]	giv[158]	_	_
23-8	3092-3097	drugs	abstract[158]|substance[159]	giv[158]|giv[159]	_	_
23-9	3098-3100	to	abstract[158]|substance[159]	giv[158]|giv[159]	_	_
23-10	3101-3108	prevent	abstract[158]|substance[159]	giv[158]|giv[159]	_	_
23-11	3109-3112	the	abstract[158]|substance[159]|event[160]	giv[158]|giv[159]|new[160]	_	_
23-12	3113-3125	transmission	abstract[158]|substance[159]|event[160]	giv[158]|giv[159]|new[160]	_	_
23-13	3126-3128	of	abstract[158]|substance[159]|event[160]	giv[158]|giv[159]|new[160]	_	_
23-14	3129-3132	the	abstract[158]|substance[159]|event[160]|abstract[161]	giv[158]|giv[159]|new[160]|giv[161]	_	_
23-15	3133-3140	disease	abstract[158]|substance[159]|event[160]|abstract[161]	giv[158]|giv[159]|new[160]|giv[161]	_	_
23-16	3141-3142	.	_	_	_	_

#Text=The science was funded by groups including UK research councils , the Spanish government , the U.S. National Institutes of Health , and the European Commission .
24-1	3143-3146	The	abstract[162]	new[162]	_	_
24-2	3147-3154	science	abstract[162]	new[162]	_	_
24-3	3155-3158	was	_	_	_	_
24-4	3159-3165	funded	_	_	_	_
24-5	3166-3168	by	_	_	_	_
24-6	3169-3175	groups	person[163]	giv[163]	_	_
24-7	3176-3185	including	person[163]	giv[163]	_	_
24-8	3186-3188	UK	person[163]|place|organization[166]	giv[163]|new|new[166]	_	_
24-9	3189-3197	research	person[163]|abstract|organization[166]	giv[163]|giv|new[166]	_	_
24-10	3198-3206	councils	person[163]|organization[166]	giv[163]|new[166]	_	_
24-11	3207-3208	,	person[163]	giv[163]	_	_
24-12	3209-3212	the	person[163]|organization[167]	giv[163]|new[167]	_	_
24-13	3213-3220	Spanish	person[163]|organization[167]	giv[163]|new[167]	_	_
24-14	3221-3231	government	person[163]|organization[167]	giv[163]|new[167]	_	_
24-15	3232-3233	,	person[163]	giv[163]	_	_
24-16	3234-3237	the	person[163]|organization[168]	giv[163]|new[168]	_	_
24-17	3238-3242	U.S.	person[163]|organization[168]	giv[163]|new[168]	_	_
24-18	3243-3251	National	person[163]|organization[168]	giv[163]|new[168]	_	_
24-19	3252-3262	Institutes	person[163]|organization[168]	giv[163]|new[168]	_	_
24-20	3263-3265	of	person[163]|organization[168]	giv[163]|new[168]	_	_
24-21	3266-3272	Health	person[163]|organization[168]	giv[163]|new[168]	_	_
24-22	3273-3274	,	person[163]	giv[163]	_	_
24-23	3275-3278	and	person[163]	giv[163]	_	_
24-24	3279-3282	the	person[163]|organization[169]	giv[163]|new[169]	_	_
24-25	3283-3291	European	person[163]|organization[169]	giv[163]|new[169]	_	_
24-26	3292-3302	Commission	person[163]|organization[169]	giv[163]|new[169]	_	_
24-27	3303-3304	.	_	_	_	_
